| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/11/2006 | EP1366036B1 Compounds having activity as inhibitors of cytochrome p450rai |
| 01/11/2006 | EP1296670B1 Therapeutic combinations of fatty acids |
| 01/11/2006 | EP1256342B1 Hypoglycemics comprising organic zinc (ii) complexes |
| 01/11/2006 | EP1131315B1 Polyhydroxylated heterocyclic derivatives as anti-coagulants |
| 01/11/2006 | EP1131310B1 Chrystals of 5- 6-(2-fluorobenzyl)oxy-2-naphthyl methyl]-2,4-thiazolidinedione |
| 01/11/2006 | EP0830450B1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof |
| 01/11/2006 | EP0766569B1 Aav capsid vehicles for molecular transfer |
| 01/11/2006 | CN1720265A Chitosan-containing polysaccharide, method for preparing the same and use thereof |
| 01/11/2006 | CN1720039A Use of docosahexanoic acid as active substance for the treatment of lipodystrophy |
| 01/11/2006 | CN1718573A Heterocyclic compound |
| 01/11/2006 | CN1718233A Capsule for treating diabetes, and its prepn. process |
| 01/11/2006 | CN1718228A Formula of essential amino acids oral-liquor and its prepn. method |
| 01/11/2006 | CN1718214A 'Lingmixiangchun' weight-reducing oral liquor |
| 01/11/2006 | CN1718213A Patent traditional Chinese medicine for treating and preventing diseases such as high blood-fat, coronary heart disease, hardening of arteries etc. |
| 01/11/2006 | CN1718195A Bee pollen tablets and its prepn. method |
| 01/11/2006 | CN1718194A Oligonucleotide medicine for treating myophagism |
| 01/11/2006 | CN1235914C Polysaccharides with antithrombotic activity comprising at least a covalent bono with biotin or a biotin derivative |
| 01/11/2006 | CN1235887C Preparation method of xazolyl alcohol derivatives |
| 01/11/2006 | CN1235877C Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity |
| 01/11/2006 | CN1235875C Substituted alpha hydroxy acid aspertate specific cysteine protease inhibitors and use thereof |
| 01/11/2006 | CN1235641C Medicinal aerosol formulation, its preparing process, use and inhaler containing same |
| 01/11/2006 | CN1235637C Methods for treating diabetes |
| 01/11/2006 | CN1235626C Oral liquid for treating diabetes and its preparing method |
| 01/11/2006 | CN1235595C Chitin soft capsule and preparing method thereof |
| 01/11/2006 | CN1235593C Regulatory factor T for cell growth, and its prepn. method |
| 01/11/2006 | CN1235586C Improved releasing composition and use thereof |
| 01/11/2006 | CN1235583C Benzimidazole derivatives as therapeutic agents |
| 01/11/2006 | CN1235570C Microball preparation for intestine orient releasing medicine and its preparing method |
| 01/10/2006 | US6984661 for preventing, Syndrome X, diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis, and other disorders related to Syndrome X and cardiovascular diseases; peroxisome proliferator activated receptor (PPAR) |
| 01/10/2006 | US6984660 To treat and/or prevent hypertension, cardiac hypertrophy, cardiac insufficiency, coronary heart diseases such as angina pectoris, and endothelial dysfunction or endothelial damage as a consequence of atherosclerotic processes or diabetes |
| 01/10/2006 | US6984650 Comprises phosphorescence and fluorescence resonance energy transfer; binding chenodeoxycholic acid to farnesoid X receptors; for regulating cholesterol absorption; for treatment of obesity |
| 01/10/2006 | US6984636 Mitochondrially targeted antioxidants |
| 01/10/2006 | US6984624 Composition containing an iron complexing protein and a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide and uses thereof |
| 01/10/2006 | CA2406745C A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 01/10/2006 | CA2383036C Solid lipid formulations |
| 01/10/2006 | CA2373395C Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors |
| 01/10/2006 | CA2370411C Diazabicyclo compounds for the treatment of schizophrenia and other disorders |
| 01/10/2006 | CA2364178C N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| 01/10/2006 | CA2327758C (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 01/10/2006 | CA2299760C Cyano containing oxamic acids and derivatives as thyroid receptor ligands |
| 01/10/2006 | CA2298549C Combinations of hmg-coa reductase inhibitors and nicotinic acid compounds and methods for treating hyperlipidemia once a day at night |
| 01/10/2006 | CA2097997C Vitamin d compounds and method of preparing these compounds |
| 01/05/2006 | WO2006001471A1 Medicinal composition for promoting glucose-responsive insulin secretion |
| 01/05/2006 | WO2006000567A2 Use of glp-1 receptor agonists and / or dpp-iv inhibitors in combination with proton pump inhibitors and ppar agonists for the preparation of a medicament for the treatment of diabetes type i i and impaired pancreatic beta-cell function |
| 01/05/2006 | WO2005095364A8 Phenoxyacetic acid derivative and medicine containing the same |
| 01/05/2006 | US20060004084 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 01/05/2006 | US20060004077 Inhibiting class II MHC-mediated activation of T cells; peptidomimetics of given sequence which include a Gpg (guanylpiperidyl glycine) unit; rheumatoid arthritis and/or multiple sclerosis; e.g. Ac-Cha-Gpg-Tic-Nle-NHCH2CH2Ph (Cha=cyclohexylalanine, Tic=3-carboxyisoquinoline, Nle=norleucine) |
| 01/05/2006 | US20060004062 Compounds for inhibiting insulin secretion and methods related thereto |
| 01/05/2006 | US20060004059 Substituted heterocycles for the treatment of diabetes and other diseases |
| 01/05/2006 | US20060004058 Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl) amino) ethoxy!benzyl!thiazolidine -2, 4-dione |
| 01/05/2006 | US20060004055 Derivative of 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(piperidine-1-yl)-1H-pyrazole-3-carboxamide, the preparation and therapeutic use thereof |
| 01/05/2006 | US20060004054 Administering 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline before or at the time angioplasty, coronary by-pass grafting or stent implantation |
| 01/05/2006 | US20060004025 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 01/05/2006 | US20060004017 Quinazoline derivatives as angiogenesis inhibitors |
| 01/05/2006 | US20060004010 Ccr4 antagonist and medical use thereof |
| 01/05/2006 | US20060004005 Triazines derivatives as cell adhesion inhibitors |
| 01/05/2006 | US20060003996 Intralesional treatment of psoriasis |
| 01/05/2006 | US20060003992 New drug combinations |
| 01/05/2006 | US20060003987 Compounds and their uses |
| 01/05/2006 | US20060003975 Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor |
| 01/05/2006 | US20060003937 Urocortin-III and uses thereof |
| 01/05/2006 | US20060003934 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 01/05/2006 | US20060003932 Method for promoting neovascularization |
| 01/05/2006 | US20060003419 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 01/05/2006 | US20060003418 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 01/05/2006 | US20060003417 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 01/05/2006 | US20060003410 Oxidoreductase for use in identifying modulators for prevention and treatment of diabetes, obesity, dyslipidemia, coronary heart, inflammatory and cancer disorders |
| 01/05/2006 | US20060003063 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 01/05/2006 | US20060003011 Pharmaceutical compositions of drugs and neutralized acidic polymers |
| 01/05/2006 | US20060002991 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same |
| 01/05/2006 | US20060002911 Association between a ppar ligand and an antioxidant agent and use thereof for treating obesity |
| 01/05/2006 | DE102004028241A1 Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New fluoroglycoside derivatives of pyrazoles, pharmaceutical compositions containing them and their use |
| 01/05/2006 | DE102004026532A1 Substituierte Oxazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung Substituted oxazole Benzoisothiazoldioxidderivate, processes for their preparation and their use |
| 01/05/2006 | CA2589563A1 Method of screening compound directly activating glycogen synthase |
| 01/05/2006 | CA2588571A1 Insulin secretagogue drugs |
| 01/05/2006 | CA2572136A1 Novel imidazoles and triazoles, the production thereof, and the use of the same as medicaments |
| 01/05/2006 | CA2572135A1 Sulfonamide compound |
| 01/05/2006 | CA2571990A1 Ortho-substituted (3-hydroxyphenyl)-acetic acid benzylidene hydrazides |
| 01/05/2006 | CA2571356A1 Novel hexafluoroisopropanol derivatives |
| 01/05/2006 | CA2570673A1 Compounds and methods for treating dyslipidemia |
| 01/05/2006 | CA2570615A1 Drugs for treating duplication of hypertension with hyperuricemia and /or hypercholesterolemia |
| 01/04/2006 | EP1612273A1 Novel physiologically active substances pf1270a, b and c |
| 01/04/2006 | EP1612266A2 Prostaglandin reductase |
| 01/04/2006 | EP1612225A1 Modified acacia and use thereof |
| 01/04/2006 | EP1612215A1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/04/2006 | EP1612206A1 Anti-obesity agent |
| 01/04/2006 | EP1612204A1 Hydrazone derivative |
| 01/04/2006 | EP1611887A2 Modulation of peroxisome proliferator-activated receptors |
| 01/04/2006 | EP1611144A1 Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl phosphonic acid and their use as n-methyl-d-aspartate (nmda) recetor antagonists |
| 01/04/2006 | EP1611121A1 Pyridazinone derivatives as cdk2-inhibitors |
| 01/04/2006 | EP1611111A2 Process for resolving 2,4-diamino-3,6-dihydro-1,3,5-triazines, useful for the treatment of disorders associated with insulin resistance syndrome |
| 01/04/2006 | EP1611109A1 Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 01/04/2006 | EP1611104A1 Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists |
| 01/04/2006 | EP1611097A1 Indole derivatives useful for the treatment of deseases |
| 01/04/2006 | EP1610789A1 Bicyclic piperidine derivatives as melanocortin-4 receptor agonists |
| 01/04/2006 | EP1610779A1 3-oxo-1,3-dihydro-indazole-2-carboxylic acid amide derivatives as phospholipase inhibitors |
| 01/04/2006 | EP1494658B1 Natural phenolic products and derivatives thereof for protection against neurodegenerative diseases |
| 01/04/2006 | EP1397153A4 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 01/04/2006 | EP1351688A4 Urotensin-ii receptor antagonists |
| 01/04/2006 | EP1311677B1 Regulation of human p2y1-like g protein-coupled receptor |